Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study

The efficacy and safety of bivalirudin in percutaneous coronary intervention (PCI) has always been a hot topic in perioperative antithrombotic therapy, but there are still some controversies. So studies are needed to provide more evidence, especially the real world study which includes patients excl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yue-cheng, Yao, Wei-jie, Jin, Dong-xia, Zhang, Jing-xia, Wang, Le, Zhang, Rui, Xu, Jing-han, Cong, Hong-liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969278/
https://www.ncbi.nlm.nih.gov/pubmed/33725878
http://dx.doi.org/10.1097/MD.0000000000025003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969278/
https://www.ncbi.nlm.nih.gov/pubmed/33725878
http://dx.doi.org/10.1097/MD.0000000000025003

Ejemplares similares